Home  About the Library What's New
 Integrity User Evaluation Trial
Trial Integrity - A Drug Discovery and Development Portal
Integrity User Evaluation Trial
The Library is pleased to announce effective immediately, a one-month evaluation trial of Integrity, a drug discovery and development portal. The trial will end on Friday, November 17, 2006.
Integrity provides structure-searchable access to more than 243,000, compounds and an array of related information in such areas as:
- Targets
- Organic Synthesis
- Experimental Pharmacology
- Pharmacokinetics / Metabolism
- Clinical Studies
- Companies and Research Institutions
- Disease Briefings with Associated Literature and Patent References
The Integrity trial includes IP address authentication along with User Name/Password log in. User identification is important for those who wish to use the various alerting features available.
Trial participants will need to self-register and then will be prompted for a log in where they will choose their own User Name/Password. This will create a cookie, and if the cookie is not erased the individual will not be asked for this information when connecting with Integrity again on that computer.
From the Integrity portal, participants will be able to access support documentation such as the Quick Tour (Flash Demo), User Guide, and FAQs under the heading, Getting started.
If you have any questions regarding the Integrity User Evaluation Trial, please contact Donna Gibson.
Content editor, Donna Gibson
Last revised: October 23, 2006 8:30 am EST
|
